{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:14:46Z","timestamp":1790028886203,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.prp.2022.154127","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:52:33Z","timestamp":1663242753000},"page":"154127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["HSP70 In triple negative breast cancer: Prognostic value and clinical significance"],"prefix":"10.1016","volume":"238","author":[{"given":"Ana Car","family":"Peterko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koraljka","family":"Rajkovi\u0107-Molek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Guli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela Veljkovi\u0107","family":"Vujaklija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Belac","family":"Lovasi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franjo","family":"Lovasi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Musta\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Avirovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.154127_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.4280","article-title":"Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes","volume":"232","author":"Lehmann","year":"2014","journal-title":"J Pathol."},{"key":"10.1016\/j.prp.2022.154127_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2022.154127_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/1055-9965.EPI-18-0863","article-title":"PAM50 molecular intrinsic subtypes in the nurses' health study cohorts","volume":"28","author":"Kensler","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.prp.2022.154127_bib4","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3390\/cancers13133357","article-title":"Tumor microenvironment: key players in triple negative breast cancer immunomodulation","volume":"13","author":"Zheng","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2022.154127_bib5","doi-asserted-by":"crossref","unstructured":"Katsuta E., Yan L., Opyrchal M., Kalinski P., Takabe K. Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer. Ther Adv Med Oncol. 202;13:17588359211006680. https:\/\/doi.org\/10.1177%2F17588359211006680.","DOI":"10.1177\/17588359211006680"},{"issue":"3","key":"10.1016\/j.prp.2022.154127_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21147\/j.issn.1000-9604.2017.03.10","article-title":"Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance","volume":"29","author":"Yu","year":"2017","journal-title":"Chin. J Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2022.154127_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Medicina."},{"key":"10.1016\/j.prp.2022.154127_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/CCO.0000000000000234","article-title":"Prognostic and predictive immune gene signatures in breast cancer","volume":"27","author":"Bedognetti","year":"2015","journal-title":"Curr Opin Oncol."},{"key":"10.1016\/j.prp.2022.154127_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152500","article-title":"The prognostic value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis","volume":"11","author":"Mao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2022.154127_bib10","first-page":"2445","article-title":"The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer","volume":"29","author":"Matkowski","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2022.154127_bib11","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-19-0469","article-title":"Immune profiles of tumor microenvironment and clinical prognosis among women with triple-negative breast cancer","volume":"28","author":"Deng","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.prp.2022.154127_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.154127_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J Clin. Oncol."},{"key":"10.1016\/j.prp.2022.154127_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.prp.2022.154127_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-cancerbio-042920-104912","article-title":"The multifaceted role of regulatory T cells in breast cancer","volume":"5","author":"Kos","year":"2021","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.prp.2022.154127_bib16","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.3390\/cancers3043740","article-title":"Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma","volume":"3","author":"Liguori","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2022.154127_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/08820130600803429","article-title":"Dendritic cells and tumor microenvironment: a dangerous liaison","volume":"35","author":"Fricke","year":"2006","journal-title":"Immunol. Invest."},{"issue":"6","key":"10.1016\/j.prp.2022.154127_bib18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/carcin\/bgt111","article-title":"The HSP70 family and cancer","volume":"34","author":"Maureen","year":"2013","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.prp.2022.154127_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-61779-295-3_16","article-title":"Hsp70: anti-apoptotic and tumorigenic protein","volume":"787","author":"R\u00e9role","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.prp.2022.154127_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/cells9030587","article-title":"HSP70 multi-functionality in cancer","volume":"9","author":"Albakova","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.prp.2022.154127_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13046-016-0425-9","article-title":"Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer","volume":"35","author":"Jagadish","year":"2016","journal-title":"J. Exp. Cancer Res."},{"key":"10.1016\/j.prp.2022.154127_bib22","first-page":"1551","article-title":"The prognostic significance of Hsp70\/Hsp90 expression in breast cancer: a systematic review and meta-analysis","volume":"38","author":"Dimas","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2022.154127_bib23","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/onc.2014.349","article-title":"Hsp70 in cancer: back to the future","volume":"34","author":"Sherman","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.154127_bib24","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.3390\/cancers13184721","article-title":"The role of extracellular HSP70 in the function of tumor-associated immune cells","volume":"13","author":"Linder","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2022.154127_bib25","unstructured":"AJCC Cancer Staging From Supplement AJCC Cancer Staging Manual, 8th ed. \u3008www.cancerstaging.orgajcc@facs.org\u3009."},{"key":"10.1016\/j.prp.2022.154127_bib26","first-page":"4757","article-title":"The invasive front of carcinomas. The most important area for tumor prognosis?","volume":"18","author":"Bryne","year":"1998","journal-title":"Anticancer Res."},{"issue":"26","key":"10.1016\/j.prp.2022.154127_bib27","first-page":"259","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"2015","author":"Salgado","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2022.154127_bib28","first-page":"69","article-title":"Statistics corner: a guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med. J."},{"key":"10.1016\/j.prp.2022.154127_bib29","article-title":"Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumors","volume":"71","author":"Chen","year":"2021","journal-title":"E Bio Med."},{"key":"10.1016\/j.prp.2022.154127_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/path.1398","article-title":"Role of tissue stroma in cancer cell invasion","volume":"200","author":"De Wever","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2022.154127_bib31","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/0008-5472.CAN-12-0122","article-title":"Tumor microenvironment complexity: emerging roles in cancer therapy","volume":"72","author":"Swartz","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2022.154127_bib32","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/cas.13101","article-title":"Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients","volume":"107","author":"Ogiya","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2022.154127_bib33","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.3390\/ijms21186968","article-title":"CD8 T cell score as a prognostic biomarker for triple negative breast cancer","volume":"21","author":"Oshi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.154127_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12885-019-5320-2","article-title":"Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer","volume":"19","author":"K\u00f6nig","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2022.154127_bib35","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.18632\/oncotarget.3958","article-title":"CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.154127_bib36","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI96313","article-title":"Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers","volume":"129","author":"Gruosso","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2022.154127_bib37","first-page":"247","article-title":"Prognostic and functional significant of heat shock proteins (HSPs) in breast cancer unveiled by multi-omics approaches","volume":"10","author":"Buttacavoli","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.prp.2022.154127_bib38","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1038\/onc.2015.1","article-title":"Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis","volume":"34","author":"Gong","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2022.154127_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1101\/gad.305405","article-title":"Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms","volume":"19","author":"Rohde","year":"2005","journal-title":"Genes Dev."},{"issue":"S1","key":"10.1016\/j.prp.2022.154127_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-8049(20)30576-1","article-title":"PD-L1 and HSP-70 molecules are part of immunosuppressive environment in the deep layer of the lymphocyte-predominant breast cancer (LPBC)","volume":"138","author":"Car Peterko","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2022.154127_bib41","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-07-0472","article-title":"A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment","volume":"13","author":"Strauss","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2022.154127_bib42","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.2147\/CMAR.S285128","article-title":"Accumulation of regulatory T Cells in triple negative breast cancer can boost immune disruption","volume":"13","author":"Zahran","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2022.154127_bib43","article-title":"FOXP3 transcription factor: a candidate marker for susceptibility and prognosis in triple negative breast cancer","volume":"2014","author":"Lopes","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.prp.2022.154127_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fimmu.2012.00095","article-title":"The anti-inflammatory mechanisms of Hsp70. The anti-inflammatory mechanisms of Hsp70","volume":"3","author":"Borges","year":"2012","journal-title":"Front Immunol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:10:42Z","timestamp":1778544642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822003715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":44,"alternative-id":["S0344033822003715"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154127","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSP70 In triple negative breast cancer: Prognostic value and clinical significance","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154127"}}